PRAVATO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 1.212
AS - Asia 615
EU - Europa 401
AF - Africa 176
SA - Sud America 131
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 9
Totale 2.565
Nazione #
US - Stati Uniti d'America 1.128
SG - Singapore 240
CN - Cina 117
IT - Italia 82
BR - Brasile 79
HK - Hong Kong 74
VN - Vietnam 45
DE - Germania 44
FI - Finlandia 29
GB - Regno Unito 25
NL - Olanda 25
PL - Polonia 22
SE - Svezia 21
BJ - Benin 19
CI - Costa d'Avorio 19
FR - Francia 17
RU - Federazione Russa 17
AT - Austria 14
AR - Argentina 13
CA - Canada 13
ES - Italia 11
MX - Messico 10
UG - Uganda 10
IN - India 9
AZ - Azerbaigian 8
IE - Irlanda 8
JM - Giamaica 8
PA - Panama 8
SN - Senegal 8
AE - Emirati Arabi Uniti 7
BB - Barbados 7
BO - Bolivia 7
CV - Capo Verde 7
ID - Indonesia 7
IR - Iran 7
KE - Kenya 7
MA - Marocco 7
TR - Turchia 7
BD - Bangladesh 6
CD - Congo 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
GN - Guinea 6
ME - Montenegro 6
MY - Malesia 6
NP - Nepal 6
TN - Tunisia 6
UY - Uruguay 6
AO - Angola 5
AU - Australia 5
BW - Botswana 5
BY - Bielorussia 5
CO - Colombia 5
HN - Honduras 5
HR - Croazia 5
HU - Ungheria 5
KR - Corea 5
LB - Libano 5
NC - Nuova Caledonia 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
TZ - Tanzania 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BS - Bahamas 4
GR - Grecia 4
IQ - Iraq 4
JO - Giordania 4
JP - Giappone 4
LV - Lettonia 4
ML - Mali 4
MN - Mongolia 4
MU - Mauritius 4
NG - Nigeria 4
PS - Palestinian Territory 4
RS - Serbia 4
RW - Ruanda 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
SO - Somalia 4
TW - Taiwan 4
VE - Venezuela 4
BE - Belgio 3
CG - Congo 3
CH - Svizzera 3
CW - ???statistics.table.value.countryCode.CW??? 3
CY - Cipro 3
DJ - Gibuti 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
EG - Egitto 3
GE - Georgia 3
GF - Guiana Francese 3
GM - Gambi 3
KG - Kirghizistan 3
KH - Cambogia 3
Totale 2.455
Città #
Ashburn 161
Fairfield 158
Singapore 140
Chandler 72
Hong Kong 72
Cambridge 61
Seattle 52
Woodbridge 48
Houston 44
Beijing 37
Los Angeles 37
Ann Arbor 34
Santa Clara 34
Chicago 28
Wilmington 27
San Diego 24
Munich 22
Boardman 20
Abidjan 19
Cotonou 19
Padova 19
Salt Lake City 18
Helsinki 17
New York 15
Ho Chi Minh City 14
Bytom 11
Elk Grove Village 11
Guangzhou 11
Hanoi 11
Medford 11
Princeton 11
Kampala 10
London 9
Dakar 8
Dallas 8
Panama City 8
Baku 7
Bridgetown 7
Vienna 7
Conakry 6
Dublin 6
Kingston 6
Montreal 6
Rio de Janeiro 6
Sterling 6
Turku 6
Amsterdam 5
Buffalo 5
Des Moines 5
Düsseldorf 5
Lancaster 5
Montevideo 5
Nairobi 5
Noumea 5
Nuremberg 5
Praia 5
São Paulo 5
Tampa 5
Tunis 5
Warsaw 5
Amman 4
Bamako 4
Detroit 4
Falkenstein 4
Gaborone 4
Kigali 4
Kuala Lumpur 4
Luanda 4
Madrid 4
Managua 4
Mexico City 4
Minsk 4
Nassau 4
Pignone 4
Podgorica 4
Quito 4
Riga 4
Roxbury 4
Tokyo 4
Ulan Bator 4
Ankara 3
Apia 3
Atlanta 3
Auckland 3
Belo Horizonte 3
Biên Hòa 3
Brooklyn 3
Casablanca 3
Castries 3
Curitiba 3
Dar es Salaam 3
Denver 3
Dili 3
Dubai 3
Ferizaj 3
Frankfurt am Main 3
Hebei 3
Hefei 3
Jakarta 3
Kinshasa 3
Totale 1.574
Nome #
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 218
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia 210
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome 207
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis 203
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia 200
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance 188
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi 183
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases 179
Ibrutinib in relapsed hairy cell leukemia variant: a case report and review of the literature 179
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia 171
Continous Treatment with Ibrutinib in 100 Untreated Patients with TP53 Disrupted Chronic Lymphocytic Leukemia. A Real‐Life Campus CLL Study 134
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness 127
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies 124
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency 101
Anaemia during venetoclax ramp-up phase: Do not forget unusual causes 100
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 87
Totale 2.611
Categoria #
all - tutte 9.077
article - articoli 9.077
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.154


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202188 0 0 0 0 3 5 7 12 21 13 20 7
2021/2022222 16 17 9 4 23 25 10 21 39 11 17 30
2022/2023153 25 11 1 17 24 21 0 8 10 5 20 11
2023/2024134 8 21 10 14 18 19 9 4 1 14 9 7
2024/2025577 0 34 27 18 53 22 23 43 51 30 88 188
2025/20261.085 147 149 266 320 203 0 0 0 0 0 0 0
Totale 2.611